A Pilot Study of Lenalidomide Maintenance Therapy after Autologous Transplantation in Relapsed or Refractory Classical Hodgkin Lymphoma-Reference-Cited by-同舟云学术

A Pilot Study of Lenalidomide Maintenance Therapy after Autologous Transplantation in Relapsed or Refractory Classical Hodgkin Lymphoma

Published:2020-12 Issue:12 Volume:26 Page:2223-2228
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Shea Lauren,Watkins Marcus P.,Wan Fei,Cashen Amanda F.,Wagner-Johnston Nina D.,Jacoby Meagan A.,Abboud Camille N.,Dipersio John F.,Hurd David D.,Jaglowski Samantha M.,Bartlett Nancy L.,Fehniger Todd A.

Funder

National Cancer Institute

National Institutes of Health

Celgene

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference33 articles.

1. Hodgkin lymphoma: a review and update on recent progress;Shanbhag;CA Cancer J Clin,2018

2. Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma;Majhail;Biol Blood Marrow Transplant,2006

3. Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial;Linch;Lancet,1993

4. Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial;Schmitz;Lancet,2002

5. Five-year PFS from the AETHERA trial of brentuximab vedotin for Hodgkin lymphoma at high risk of progression or relapse;Moskowitz;Blood,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of transplantation in Hodgkin lymphoma;Frontiers in Oncology;2023-01-26

2. Novel Agents For Relapsed and Refractory Classical Hodgkin Lymphoma: A Review;Frontiers in Oncology;2022-07-14

3. Disease Status at Transplant has a Significant Impact on Outcomes of Autologous Transplantation (ASCT) in Patients with Hodgkin Lymphoma—A Single Center Experience;Indian Journal of Hematology and Blood Transfusion;2021-05-27